Hypera Pharma

Hypera S.A.
Type	Sociedade Anônima
Traded as	B3: HYPE3; Ibovespa Component
Industry	Pharmaceuticals
Founded	2001
Headquarters	São Paulo, Brazil
Key people	Claudio Bergamo,(CEO)
Products	Drugs; Healthcare; Cosmetics
Revenue	US$ 1.1 billion (2017)[1]
Net income	US$ 297.8 million (2017)[1]
Number of employees	6.500
Subsidiaries	Mantecorp
Website	www.hyperapharma.com.br

Hypera Pharma previously known as Hypermarcas is the Brazilian largest pharmaceutical company by market capitalization. Its headquarters are located in São Paulo. The company was formerly known as Hypermarcas, before a corporate name change that was announced in December 2017.^[2] The official corporate name change is pending approval by the company's Shareholders' Meeting.

Hypera Pharma's main market segments are Consumer Health, Branded Prescription and Branded Generics.

References

1 2 Terra.com (Portuguese language) Archived 2011-07-06 at the Wayback Machine.
↑ "Hypermarcas quer crescer até 3% acima do mercado em quatro anos". Valor Econômico (in Portuguese). 2017-12-04.

External links

Hypera Pharma

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

[terra-1] 1 2 Terra.com (Portuguese language) Archived 2011-07-06 at the Wayback Machine.

[2] "Hypermarcas quer crescer até 3% acima do mercado em quatro anos". Valor Econômico (in Portuguese). 2017-12-04.